Arman W. Mohammad

Broad Institute — United States

Medicine · Health Sciences

8h-index758citations42works16.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(36), Acute Lymphoblastic Leukemia research(27), Advanced Breast Cancer Therapies(10), Immunodeficiency and Autoimmune Disorders(7), Chronic Myeloid Leukemia Treatments(6)

Publications42 total

Comparative genomics of the closely related fungal genera Cryptococcus and Kwoniella reveals karyotype dynamics and suggests evolutionary mechanisms of pathogenesis
PLoS Biology·2024· 16 citedOpen Access
Comparative genomics of <i>Cryptococcus</i> and <i>Kwoniella</i> reveals pathogenesis evolution and contrasting karyotype dynamics via intercentromeric recombination or chromosome fusion
2023Open Access
Figure S5 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Supplementary Figures and Legends from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S2 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Data from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S2 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S4 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S7 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S2 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S7 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Data from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S1 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S4 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Table S3 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S6 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
Figure S3 from Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Andreas Gnirke(42), Alexander Meissner(38), Donna Neuberg(37), Catherine J. Wu(37), Laura Z. Rassenti(35), Thomas J. Kipps(35), Helene Kretzmer(34), Anat Biran(34), Jennifer R. Brown(34), Stacey M. Fernandes(32), Lili Wang(32), Kendell Clement(30), Hongcang Gu(28), Sven Klages(26), Bernd Timmermann(26), Noelia Purroy(25), Camilla K. Lemvigh(25), Michaela Gruber(25), Connie Lesnick(25), Susan L. Slager(25)